Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02740985
Title A Phase 1 Clinical Study of AZD4635 and Durvalumab in Patients With Advanced Solid Malignancies
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors AstraZeneca
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Research Site Fayetteville Arkansas 72703 United States Details
Research Site Fresno California 93720 United States Details
Research Site Denver Colorado 80218 United States Details
Research Site New Haven Connecticut 06519 United States Details
Research Site Daytona Beach Florida 32117 United States Details
Research Site Lecanto Florida 34461 United States Details
Research Site North Port Florida 34288 United States Details
Research Site Sarasota Florida 34232 United States Details
Research Site Decatur Illinois 62526 United States Details
Research Site Las Vegas Nevada 89119 United States Details
Research Site New York New York 10032 United States Details
Research Site Durham North Carolina 27710 United States Details
Research Site Oklahoma City Oklahoma 73104 United States Details
Research Site Philadelphia Pennsylvania 19107 United States Details
Research Site Myrtle Beach South Carolina 29572 United States Details
Research Site Chattanooga Tennessee 37404 United States Details
Research Site Nashville Tennessee 37203 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field